AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2692-9759/083
1 King Fahad cardiac Centre, College of Medicine, King Saud University Medical City, Saudi Arabia.
2 AlFaisal University, College of Medicine, Riyadh, Saudi Arabia.
3 Universiti Sains Malaysia (USM), Malaysia.
*Corresponding Author: heart failure outcome; troponin leak; ICD therapy; ICD shocks
Citation: Fakhr Z. AlAyoubi, Hayajneh A., Tariq A. Alam, Kazi N. Asfina, Siti M.S. Ghadzi, et al, (2023) Cost of Heart Failure in-patient in Saudi Arabia: Role of Heart Failure Multidisciplinary Program. Cardiology Research and Reports. 5(1); DOI:10.31579/2692-9759/083
Copyright: © 2023 Fakhr Z. AlAyoubi, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 26 December 2022 | Accepted: 30 December 2022 | Published: 09 January 2023
Keywords: heart failure outcome; troponin leak; ICD therapy; ICD shocks
Background: Globally, the prevalence of heart failure (HF) is rising in many countries, same as in Saudi Arabia but the economic burden of direct and indirect costs for HF hospitalization and re-hospitalization are not well studied in Saudi Arabia. The aim of this study was to assess the efficiency of the newly established multidisciplinary HF team at King Saud University Medical City (KSUMC) in reducing the costs of each HF patient per year.
Material & Methods: A non-interventional retrospective prevalence-based single-center King Fahad Cardiac Centre (KFCC) study was conducted with all the HF in-patients from January 2014 to December 2019 at KSUMC.
Results: The study included a total of 943 patients, where 531 were male, a study period of 6 years. The mean age was 61.65 ± 1.9 year, the median length of stay (LOS) was 11.6 days (compared to the global average which is 4-5 days), BMI was 29.9, the median NT-proBNP was 6015.3 pg/ml and NYHA was 2.9. Hypertension (HTN), Diabetes (DM), dyslipidemia and coronary artery disease (CAD) were the most commonly reported comorbidities in the study period. As per the recent study for Middle East (ME) countries (Egypt, Saudi Arabia and UAE), the average cost per year per patient was 8137 $. The patient’s admission and readmission cost, which were the direct costs, was the major cost driver ranging from 25% to 56% of total cost, therefore, the average admission cost was 30% of total cost. Hence the admission cost for each patient per year was 8137 $ x 30% = 2441 $. The readmission cost in 2014 was $ 90317 and in 2015 was $ 19528, which was represented a drop of 78.4%. In 2016, it was $ 17087 showing a drop of 81%. In 2017, it was 86.5% and 83.9% respectively in 2018 and 2019. The indirect medical costs were estimated based on a human capital approach.
Conclusions: Our HF program has a role to keep up the positive outcomes by reducing the HF readmission, hence reduce the direct and indirect costs. We were able to reduce the re-hospitalization for NYHA Class-2 by managing in outpatient clinics and therefore reducing the total cost of HF per year. We can improve the research quality by adding higher numbers of patients with more geographical representation and estimation of other costs, such as indirect costs may be needed in future studies.
Heart failure (HF) is a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and supported by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion [1]. HF is a global health problem that is associated with poor quality of life and an ever-rising healthcare cost ($24,383 per patient) [2]. Primary goals of HF therapy are to slow down progression of symptoms, improve patient’s quality of life, prolong survival, and decrease cost [3].
The New York Heart Association (NYHA) functional classification by far, is the most used classification system which places heart failure patients in one of four categories based on how much they are limited during physical activity [4].
Despite these goals, morbidity and mortality remain high in managing heart failure [5, 6]. It accounts for 5
2.1 Design and Population:
We conducted a non-interventional retrospective prevalence-based single-centre study at KSUMC to assess the effectiveness of creating multidisciplinary team based (certified HF cardiologists, qualified HF nurses, clinical cardiac pharmacists, dietitians, and health educators) HF program for patients with HF in January 2015 at King Fahd Cardiac Centre (KFCC) Riyadh, Saudi Arabia under the umbrella of KSUMC. This HF program was involved in both outpatient services as well as inpatient. Our study was for the inpatient cost of care. The study population was from January 2014 to December 2019.This was assisted by establishing a HF database, which reflects the comparison of the annual cost of each HF hospitalized patient before and after the initiation of the program. Based on the latest HF guidelines, the diagnosis of heart failure and the standard variables definitions were in accordance with the European Society of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with heart failure [33, 34]. The cost was compared with a public sector perspective (e.g Ministry of Health). We obtained the Saudi Arabian GDP per capita for the year 2020 from the World Bank database and used it as an index for evaluating indirect costs [35]. The total cost was calculated in US dollars (1 USD= 3.75 Saudi riyals).
Direct costs for our study were involved with general physician and specialist physician services, non-physician personnel services, emergency services, hospitalization without surgical services (acute and chronic diseases), day clinic services, diagnostic services (including laboratory, imaging and genetic counseling clinic), health services as non-official person (who are ineligible approved by the Ministry of Health) and the indirect costs covered patient transportation expenses to receive health services along with the family, patient and the family housing costs (other than admission), expenses related to the patient’s temporary and permanent disability due to illness, for the foods, communication technologies (telephone, Internet, etc.) and related to the patient’s changing jobs were estimated based on human capital approach for Saudi Arabia.[36]
2.2 Data Collection:
Secondary data of all patients included in this study were collected by constructing a paper-based case record form (CRF) which were extracted using our Electronic Medical Records (EMR) for all consecutive KSUMC hospitalized acute on top of chronic and de novo (newly diagnosed) HF patients aged more than 18 years for a study period of 6 years (2014-2019), to capture the entire spectrum of medical care for heart failure patients. [37] As per the inclusion criteria, we filtered the eligible patients' Medical Record Numbers (MRN) after getting the Institutional Review Board (IRB) approval and completed the designated CRF of the study. It is a retrospective, prevalence-based, observational single-centre study and the study proposal was gone through expedited review by the Ethical Committee of KSUMC (IRB # E-16 1981).
The following information were captured for each patient in this study:
2.2.1 Demographics: age in years, gender, duration of admissions and readmission.
2.2.3 Direct Cost: We have used the information from our recent study from KSUMC in 2018, for the total cost of each HF hospitalized patient and then calculated the direct cost which were general physician and specialist physician services, non-physician personnel services, emergency services, hospitalization without surgical services (acute and chronic diseases), day clinic services, diagnostic services (including laboratory, imaging and genetic counseling clinic) for all HF re-hospitalized patients before and after the establishment of the HF program. Then we have compared each HF hospitalized patient’s direct cost per year for the period of 5 years from 2014 [32].
2.2.4 Checklist for the cost calculation: The checklist was developed based on recommendations of the HF guidelines and included the use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), ß-blockers, and influenza and pneumococcal immunizations [38]. It also had a section for education, including medications, which was carried specifically by the clinical pharmacist. We assessed the effect of the checklist on adherence to such a regimen in terms of 30-day readmission rates.
2.3 Statistical Methods and Data Analysis: We performed descriptive statistics, including the calculation of means, standard (SD), and frequencies. Additionally, we used inferential statistics as needed, including t-test and the analysis of variance (ANOVA) tests to compare the cost of HF groups. We also performed a Linear regression analysis to analyze the association between the estimated costs and different variables, such as age, gender, EF, and comorbidities. All p-values less than 0.05 were considered statistically significant. We conducted statistical analyses using the Statistical Package for the Social Sciences (SPSS) version 23 (SPSS Inc., Chicago, IL, USA).
The study included a total of 943 patients covering the period from January 2014 to December 2019. The total number of male patients was 531 as well as total number of female was 412 for the entire study period of 6 years. The mean age was 61.65 ± 1.9 years, and the average length of stay (LOS) was 11.6 days (compared to Global average which is 4-5 days). The average BMI was 29.9. The age group, LOS and BMI has been near about constant throughout these 5 years.
The table 1 showed that, Hypertension (HTN), Diabetes (DM), Dyslipidaemia and Coronary Artery Disease (CAD) were the most reported comorbidities in the study period. We were unable to collect some variables retrospectively for 2014, before the built up of HF program. Through the HF program, we were able to capture hypothyroidism, anaemia, coronary artery diseases (CAD) and DM: Diabetes Mellites, dyslipidaemia accurately, which were managed by the efficient teamwork in the program and eventually the re-admission was reduced for these associated comorbidities, shown in table 1. As per the NYHA classification, average class was 2.9. In 2014 and 2015, the patients were admitted and re-admitted with average NYHA class 2.3, but after the fully establishment of the program, we were able to manage such group in the outpatient clinic.
Abbreviation: DM: Diabetes Mellites, HTN: Hypertension, COPD: Chronic Obstructive Pulmonary Disease, CAD: Coronary Artery Disease,
Table 1: Patient’s disease characteristics.
As per the recent study for Middle East (ME) countries i.e., Egypt, Saudi Arabia and UAE, the average cost per year per patient was 8137 $. The patient’s admission and readmission cost, which is the direct cost, is the major cost driver ranging from 25% to 56% of total cost, therefore, the average admission cost was 30% of total cost. Hence the admission cost for each patient per year was 8137 $ x 30% = 2441 $.
Figure 1 below demonstrates that for the readmission of 37 patients in 2014, the total cost was $ 90317 using the Middle East and North America (MENA) cost and for 8 readmissions in 2015, total cost was $ 19528, representing a drop of 78.4%. In 2016, for 7 readmissions, the total cost was $ 17087 showing a drop of 81%. In 2017, it was 86.5% for 5 readmissions despite having the highest average comorbidities but lowest number of readmissions, in comparison of other years in our study. Finally, there was 6 readmissions with the total cost of $ 14646, representing a drop of 83.9%, maintained for 2018 and 2019 successively.
Figure 1: Direct readmission cost.
Table 2 shown the laboratory values for our study period. The average values of all the parameters were constant throughout the journey of our study, but we were able reduce the readmission of the HF patients. This represents a steady outcome after the establishment of the multidisciplinary team.
| Years | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Average |
| Hb | 12 | 12.6 | 11.9 | 11.8 | 12 | 12.1 | 12.1 |
| FERRITIN | 347.2 | 187.2 | 191.9 | 202.7 | 202.7 | 187.4 | 219.9 |
| URIC ACID | 458.7 | 515.5 | 482.9 | 487.9 | 514.1 | 491.5 | 491.8 |
| TSH | 4.8 | 4.8 | 3.6 | 4.1 | 4.9 | 2.8 | 4.2 |
| T4 FREE | 16.6 | 16.9 | 17.3 | 16.8 | 17.2 | 16.7 | 16.9 |
| PRO-BNP | 5943.3 | 6182.9 | 6384.7 | 5742.3 | 6486.5 | 5352.3 | 6015.3 |
| Na + | 133 | 133.1 | 133.5 | 135.6 | 135.5 | 135.9 | 134.4 |
| K+ | 4.8 | 4.2 | 4.2 | 4.2 | 5.7 | 5.1 | 4.7 |
| UREA | 13.9 | 12 | 13.6 | 15.2 | 17.9 | 17.6 | 15.0 |
| CREATININE | 52 | 126 | 140.2 | 141.2 | 157.9 | 156.6 | 129.0 |
| Mg+ | no data | 1.3 | 0.8 | 0.9 | 0.9 | 0.9 | 1.0 |
| SBP | no data | 113.9 | 110.6 | 111.4 | 110.9 | 113.7 | 112.1 |
| DBP | no data | 65.5 | 62.3 | 62.7 | 62.6 | 64 | 63.4 |
| HR | no data | 76.4 | 75 | 76.3 | 73.9 | 78.8 | 76.1 |
Table 2: Laboratory findings.
The estimation of the economic impact of HF on society is a great tool that provides valuable information about the use of health resources and the country’s expenditure on this disease. This will help decision makers in prioritizing healthcare policies, implementing interventions, and efficiently allocating the available health resources [38, 39].
Inpatient HF expenditure was subdivided for direct and indirect medical costs.
We aimed to develop an efficient multidisciplinary team to improve the quality of life for HF patients which eventually will increase the cost-effectiveness in heart failure. Outcome of the HF improved by adherence to the guideline-directed medical therapy (GDMT). The GDMT is for heart failure with reduced ejection fraction (HFrEF) and is recommended prior to primary prevention implantable cardiac defibrillator (ICD) placement [40]. The GDMT as shown in the appendages, were invented by our hard-working team. We had created our own HF assessment checklists to assess accurately and properly by the physicians and nurse’s specialist, titrating of medications by experienced clinical pharmacist through the medication checklist and introducing seasonal jabs checklist, echo instruction, smoking cessation counseling and dietary counseling in three separate checklists for adjusting the outcome, checklists were a helpful tool for gathering the information needed for KSUMC heart failure patients data. . We had constructed a walk-in clinic for closely monitoring patients within 2-3 weeks of discharging from the outpatient clinic.
In 2017, the patient numbers increased with all the comorbidities but by strictly adhering to our own GDMT through the efficient HF program, we were able to maintain homogenous stability.
The role of the HF Consultant from this multidisciplinary team was, to diagnose the patient and carefully evaluate the patient’s symptoms, be alert and ask for common verbal descriptors of NYHA by using his experience to classify which class of the patient fits, assess Jugular venous pressure (JVP), echocardiogram, laboratory work (for example; Brain Natriuretic Peptide (BNP) and label the patient as HF with NYHA classification.
The HF Clinical Pharmacist from the team played the most important role in both aspects of pharmacological and non-pharmacological management. They ensured the initiation of ACEI/ ARBs, BBs, and others to all HF patients and achieved the targeted therapy dose. They gave proper education and counseling about contraindications, intolerance, or other reasons to HF team in collaboration with the patients and caregivers for not utilizing proper therapies [41]. They prevent, detect, and resolves medication-related problems and provide comprehensive, and timely responses to drug information requests as well as they document the source of scientifically valid information and advice regarding the safe, appropriate, and cost-effective use of medicines and develop, review, and evaluates clinical guidelines for medications used in stated management protocol with GDMTs according to evidence, compliance with prescription during hospitalization and delivery of adequate patient education regarding medication use and follow-up, thereby improving the outcome of patients with HF [42,43].
During the transition of patients from the setting of inpatient to outpatient and being assessed by different caregivers, pharmacists play a positive role by influencing medical reconciliation and patients’ education, which will result in assuring consistency in management and reducing medication errors. Utilizing GDMT, this will decrease emergency department visits, hospitalizations for HF, and all-cause readmissions for patients with HF. We were able to evaluate patients’ adherence to medications by controlling polypharmacy problems in chronically ill patients and appointments throughout the program [44-46].
The nurses play an important role by establishing a link between the patient and the multidisciplinary team for optimal care. They educate patients on the meaning of HF and provide several strategic plans and counseling. They ensure that the patients are closely following their discharge instructions and emphasize adhering to GDMT while also focusing on timely follow up. Having nurse specialists in the multidisciplinary team increases the proper use of evidence-based HF therapies [47-48].
Figure 2 shows the KPIs checklists, for example, discharge patient on ACEi or ARB /Angiotensin receptor neprilysin inhibitor, discharge patient on beta blockers, as well as instructions upon discharge, etc. [49-50-51].
Figure 2: Heart Failure checklist
This study aimed to estimate the cost of HF treatment for the hospitalized patients using real world data. However, the study has some limitations. The study is limited to the tertiary care center which might be more enthusiastic about adhering to guidelines and evidence-based practice and this may explain the high prescription rate of medication at baseline. There is also limited geographic representation compared with other countries. The observational nature of the study with the inherent selection bias was another weakness. Observational studies are especially prone to its many forms, mainly due to the investigator's lack of control over the study. Selection bias may result when a study fails to select a representative sample from the population of interest, limiting the applicability of the study's results. In the estimation of direct costs, the study focused on direct medical costs and did not include indirect costs, such as that of transportation and housing for patients visiting from outside Riyadh. Although the study represents a large public healthcare institution in Riyadh, it does not account for those in other large institutions at a national level and from the private sector. Due to pandemic crisis caused by Covid-19, data was collected for 2020 but due to high emergency extensive care from intensive care Unit (ICU) admission and use of the resources unexpectedly, was not included to contaminate the data.
Our program has a role to keep up the positive outcomes by reducing the HF readmission, hence reduce the direct and indirect cost. We were able to do reduce the re-hospitalization for NYHA class II by managing the group in outpatient clinics and therefore reducing the total cost of HF per year after establishing and succeeding the goal of HF program.
We can improve the research quality by adding higher numbers of patients with more geographical representation and estimation of other costs, such as indirect costs may be needed in future studies.
Funding: This research received no external funding.
Institutional Review Board Statement: This study was approved by the Institutional Review Board (IRB) Committees at KSUMC (IRB # E-16 1981).
Informed Consent Statement: Informed consent was not obtained from the subjects as per the IRB protocol of the retrospective observational study.
Data Availability Statement: Data sharing not applicable.
Acknowledgments: The authors would like to extend their sincere appreciation to the
Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia).
Conflicts of Interest: The authors declare no conflict of interest.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
